Cancer BiologybioRxivPreprint
Amplicon structure creates collateral therapeutic vulnerability in cancer
Y. Bei, L. Brame, M. Kirchner…·A. Henssen
The paper identifies DDX1 as a passenger gene co-amplified with MYCN in cancer, showing that its aberrant expression creates a therapeutic vulnerability through mTORC1 dependency.
DOI 10.1101/2022.09.08.506647